These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 13488106)

  • 21. Calcium-magnesium excretion in the urine of healthy and cancer patients.
    STRIEBEL A; BAUR H
    Schweiz Med Wochenschr; 1954 Sep; 84(38):1082-5. PubMed ID: 13216144
    [No Abstract]   [Full Text] [Related]  

  • 22. [Magnesium metabolism. Report on the 4th Hohenheimer Magnesium Symposium, Sept. 26-27, 1980].
    Fortschr Med; 1980 Dec; 98(46):1831-2. PubMed ID: 7274920
    [No Abstract]   [Full Text] [Related]  

  • 23. [Calcium and magnesium excretion in urine in breast cancer as evaluation of testosterone therapy].
    STRIEBEL A; VON PLANTA P; VIOLLIER G
    Schweiz Med Wochenschr; 1955 Feb; 85(8):167-70. PubMed ID: 14358628
    [No Abstract]   [Full Text] [Related]  

  • 24. [An experimental study of effect of different extracts of Alisma orientalis on urinary calcium oxalate stones formation in rats].
    Cao ZG; Liu JH; Radman AM; Wu JZ; Ying CP; Zhou SW
    Zhongguo Zhong Yao Za Zhi; 2003 Nov; 28(11):1072-5. PubMed ID: 15615421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization.
    Siener R; Jahnen A; Hesse A
    Eur J Clin Nutr; 2004 Feb; 58(2):270-6. PubMed ID: 14749747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary calcium and magnesium in hyperparathyroidism.
    White RW
    Lancet; 1969 Jun; 1(7607):1215. PubMed ID: 4181870
    [No Abstract]   [Full Text] [Related]  

  • 27. Antilithiatic effect of Asparagus racemosus Willd on ethylene glycol-induced lithiasis in male albino Wistar rats.
    Christina AJ; Ashok K; Packialakshmi M; Tobin GC; Preethi J; Murugesh N
    Methods Find Exp Clin Pharmacol; 2005 Nov; 27(9):633-8. PubMed ID: 16357948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.
    Damasio B; Massarino F; Durand F; Banchero R; Bottino P; De Franchis V; Carmignani G; Cannella G
    J Nephrol; 2005; 18(3):262-6. PubMed ID: 16013013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excretion of factors concerned in the formation of urinary calcium calculi after the administration of acetylsalicylic acid and glucoronolactone.
    HAMM FC; WEINBERG SR; KARANSKY D; KESNER L; LEWIS P
    Surg Forum; 1957; 8():629-33. PubMed ID: 13529701
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of potassium-magnesium citrate supplementation on cytosolic ATP citrate lyase and mitochondrial aconitase activity in leukocytes: a window on renal citrate metabolism.
    Tosukhowong P; Tungsanga K; Phongudom S; Sriboonlue P
    Int J Urol; 2005 Feb; 12(2):140-4. PubMed ID: 15733107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some medical aspects of nephrolithiasis. II.
    BERG P
    Med Times; 1957 May; 85(5):517-23. PubMed ID: 13417978
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus.
    Liu J; Chen J; Wang T; Wang S; Ye Z
    J Urol; 2005 Jan; 173(1):113-6. PubMed ID: 15592049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of calciuria during renal lithiasis complicated by renal insufficiency].
    FEY B; LEGRAIN M
    J Urol Medicale Chir; 1958 Jun; 64(6):375-9. PubMed ID: 13599178
    [No Abstract]   [Full Text] [Related]  

  • 34. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors.
    Taylor EN; Mount DB; Forman JP; Curhan GC
    Am J Kidney Dis; 2006 May; 47(5):780-9. PubMed ID: 16632016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of renal lithiasis.
    Grases F; Costa-Bauzá A; Ramis M; Montesinos V; Conte A
    Scand J Urol Nephrol; 2003; 37(6):482-6. PubMed ID: 14675921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placebo-controlled study of intravenous magnesium supplementation during large-volume leukapheresis in healthy allogeneic donors.
    Haddad S; Leitman SF; Wesley RA; Cecco S; Yau YY; Starling J; Rehak NN; Bolan CD
    Transfusion; 2005 Jun; 45(6):934-44. PubMed ID: 15934992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levels of calcium, magnesium and zinc in urine among adult women in relation to age with special reference to menopause.
    Ikeda M; Ezaki T; Moriguchi J
    J Nutr Health Aging; 2007; 11(5):394-401. PubMed ID: 17657361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of urinary glucuronide on solubility of calcium phosphate and stone formation: experimental urolithiasis. XII.
    VERMEULEN CE; FINLAYSON B; CHAPMAN W
    Postgrad Semin Am Urol Assoc North Cent; 1956-1957; ():142-52. PubMed ID: 13567660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.